Darolutamide Extends Survival in Metastatic Prostate Cancer - NCI
Por um escritor misterioso
Descrição
Adding darolutamide (Nubeqa) to ADT and docetaxel improves survival in hormone-sensitive metastatic prostate cancer, results from the ARASENS trial show.
Abiraterone acetate plus prednisolone with or without enzalutamide
Bayer expands global clinical program for darolutamide in prostate
Nubeqa Delays Prostate Cancer Progression in Resistant Prostate
Cancers, Free Full-Text
Nubeqa Delays Prostate Cancer Progression in Resistant Prostate
Prostate Cancer Treatment (PDQ®) - PDQ Cancer Information
PDF) Efficacy and safety of darolutamide in Japanese patients with
The Hospitalization-Related Costs of Adverse Events for Novel
Are Bacteria and AI Taking the Stealth Out of Prostate Cancer
Selected Ongoing Trials With Darolutamide In Prostate Cancer
Quick Take: Darolutamide in Advanced Prostate Cancer
Frontiers Recent Discoveries in the Androgen Receptor Pathway in
Nonmetastatic, Castration-Resistant Prostate Cancer and Survival
de
por adulto (o preço varia de acordo com o tamanho do grupo)
